Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue

World Journal of Gastroenterology

Volumn 11, Issue 28, 2005, Pages 4404-4408

  Niu, Zhao Shan ^a   Wang, Mei ^b  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

C erbB 2 gene; GST pi gene; Hyperplastic nodule; Immunohistochemistry; Liver neoplasm

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 23244433372     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i28.4404     Document Type: Article

References (31)

1. Zhou BP, Hung MC. Dysregulation of cellular signaling by HER2/neu in breast cancer. Semin Oncol 2003; 30 (5 Suppl 16): 38-48
2. Bankfalvi A. HER-2 diagnostics. Magy Onkol 2002; 46: 11-15
3. Nathanson DR, Culliford AT 4th, Shia J, Chen B, D'Alessio M, Zeng ZS, Nash GM, Gerald W, Barany F, Paty PB. HER 2/neu expression and gene amplification in colon cancer. Int J Cancer 2003; 105: 796-802
4. Lazar H, Baltzer A, Gimmi C, Marti A, Jaggi R. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. Int J Cancer 2000; 85: 578-583
5. Kumar R, Yarmand-Baagheri R. The role of HER2 in angiogenesis. Semin Oncol 2001; 28 (5 Suppl 16): 27-32
6. Zhang L, bewick M, Lafrenie RM. EGFR and ErbB2 differentially regulate Raf-1 translocation and activation. Lab Invest 2002; 82: 71-78
7. Vlasoff DM, Baschinsky DY, De Young BR, Morrison CD, Nuovo GJ, Frankel WL. C-erbB2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms. Appl Immunohistochem Mol Morphol 2002; 10: 237-241
8. Shi G, Sun C, Han X, Meng X, Wang M, Gu M. Expression of rasp21, C-myc, C-erbB-2, and AFP in 2-FAA induced experimental hepatocarcinogenesis. Zhonghua Ganzangbing Zazhi 2001; 9: 98-99
9. Neve RM, Lane HA, Hynes NE. The role of overexpressed HER2 in transformation. Ann Oncol 2001; 12(Suppl 1): S9-13
10. Yu D, Hamada J, Zhang H, Nicolson GL, Hung MC. Mechanisms of c-erbB-2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene 1992; 7: 2263-2270
11. Kusakari T, Kariya M, Mandai M, Tsuruta Y, Hamid AA, Fukuhara K, Nanbu K, Takakura K, Fujii S. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. Br J Cancer 2003; 89: 2293-2298
12. Lian ZR. HBV status and expression of ets-2, IGF-II, C-myc and N-ras in human hepatocellular carcinoma and adjacent nontumorous tissues-a comparative study. Zhonghua Zhongliu Zazhi 1991; 13: 5-8
13. Sawaki M, Hattori A, Tsuzuki N, Sugawara N, Enomoto K, Sawada N, Mori M. Chronic liver injury promotes hepatocarcinogenesis of the LEC rat. Carcinogenesis 1998; 19: 331-335
14. Nishikawa T, Wanibuchi H, Ogawa M, Kinoshita A, Morimura A, Hiroi T, Funae Y, Kishida H, Nakae D, Fukushima S. Promoting effectsof monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism. Int J Cancer 2002; 100: 136-139
15. Shukla Y, Arora A. Enhancing effects of mustard oil on preneoplastic hepatic foci development in Wistar rats. Hum Exp Toxicol 2003; 22: 51-55
16. Imai T, Masui T, Ichinose M, Nakanishi H, Yanai T, Masegi T, Muramatsu M, Tatematsu M. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization. Carcinogenesis 1997; 18: 545-551
17. Satoh K, Itoh K, Yamamoto M, Tanaka M, Hayakari M, Ookawa K, Yamazaki T, Sato T, Tsuchida S, Hatayama I. Nrf2 transactivator-independent GSTP1-1 expression in "GSTP1-1 positive"single cells inducible in female mouse liver by DEN: a preneoplastic character of possible initiated cells. Carcinogenesis 2002; 23: 457-462
18. Satoh K, Hatayama I. Anomalous elevation of glutathione S-transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats. Carcinogenesis 2002; 23: 1193-1198
19. Tatematsu M, Mera Y, Inoue T, Satoh K, Sato K, Ito N. Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of gamma-glutamyltransferase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis 1988; 9: 215-220
20. Yusof YA, Yan KL, Hussain SN. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease. Anal Quant Cytol Histol 2003; 25: 332-328
21. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998; 58: 4515-4518
22. Miyanishi K, Takayama T, Ohi M, Hayashi T, Nobuoka A, Nakajima T, Takimoto R, Kogawa K, Kato J, Sakamaki S, Niitsu Y. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 2001; 121: 865-874
23. Esteller M. CpG island hypermethylation and tumor suppressor gene: a booming present, a brighter future. Oncogene 2002; 21: 5427-5440
24. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin Cancer Res 2002; 8: 1087-1092
25. Bakker J, Lin X, Nelson WG. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J Biol Chem 2002; 277: 22573-22580
26. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of suppressor genes in hepatocellular carcinoma. Am J Pathol 2003; 163: 1101-1107
27. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 2003; 163: 1371-1378
28. Ruscoe JE, Rosario LA, Wang T, Gate L, Arifoglu P, Wolf CR, Henderson CJ, Ronai Z, Tew KD. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1(GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 2001; 298: 339-345
29. Goto S, Kamada K, Soh Y, Ihara Y, Kondo T. Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs. Jpn J Cancer Res 2002; 93: 1047-1056
30. Hara T, Ishii T, Fujishiro M, Masuda M, Ito T, Nakajima J, Inoue T, Matsuse T. Glutathione S-transferase P1 has protective effects on cell viability against camptothecin. Cancer Lett 2004; 203: 199-207
31. Chandra RK, Bentz BG, Haines GK 3rd, Robinson AM, Radosevich JA. Expression of glutathione S-transferase pi in benign mucosa, Barrett's metaplasia, and adenocarcinoma of the esophagus. Head Neck 2002; 24: 575-581